Back to Journals » ImmunoTargets and Therapy » Volume 6
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,519 | Dovepress* | 10,334+ | 1,581 | 11,915 | |
PubMed Central* | 1,185 | 251 | 1,436 | ||
Totals | 11,519 | 1,832 | 13,351 | ||
*Since 2 May 2017 |
View citations on PubMed Central and Google Scholar